EPO and type 2 diabetes mellitus: Anaemia resulting from CKD in type 2 diabetes is due to impaired production of erythropoietin by peritubular fibroblasts, nutritional deficiencies (iron, folate, and B12), inadequate response to erythropoietin, and background proinflammatory conditions.